Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in the December 2012 issue of The American Journal of Managed Care® (AJMC®) spoke of the importance of emotional and practical support in promoting medical adherence. The study, “Association Between Different Types of Social Support and Medication Adherence,” was highlighted in an article by Stabroek News.
A blog post on drug pricing in Health Affairs highlighted 4 articles from AJMC®’s sister site The Center for Biosimilars®. The articles referenced included the following: “Amgen and Allergan Launch Mvasi and Kanjinti, the First Anticancer Biosimilars, in the United States,” “Mylan Confirms That It Has Launched Fulphila in the United States,” “Apobiologix Launches Pegfilgrastim Biosimilar in Canada,” and “Mundipharma Launches Biosimilar Pegfilgrastim in Germany, the Netherlands, and Ireland.”
An article appearing in Newsweek detailed the passage of the Workplace Violence Prevention for Healthcare and Social Service Workers Act in the US House of Representatives last Friday. The article referenced a 2019 AJMC® newsroom article titled “Violence Against Healthcare Workers: A Rising Epidemic,” which stressed that more attention is warranted to increasing rates of violence against employees in the field of healthcare.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More